Cystic Fibrosis Foundation issued the following clinical trial alert on August 24, 2020.
Description: This two-part observational study will look at the effects of CFTR modulators on growth in infants and young children with CF. These drugs are intended to help CFTR protein function closer to normal.
Age: 0 Years to 6 Years
Mutation: No Mutation Requirement
Fev1% Predicted: No FEV1 Limit
Number of Visits: 6
Length of Participation: 3 years
ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04509050